Dr. Icilma V. Fergus, MD

Dr. Fergus practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Fergus' NPI, 1699745075, was assigned on January 26, 2006. Dr. Fergus graduated from State University of New York Downstate Medical Center in 1992. Dr. Fergus holds New York license 206086.

Dr. Fergus' primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Fergus also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Fergus' primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Fergus is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Fergus to 3 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fergus practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Fergus' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Fergus is licensed in New York.

CMS data shows 3,910 Medicare services from Dr. Fergus across 10 procedure codes in 2024, for 735 Medicare patients. Medicare paid $95,194 for them.

CMS counts 735 Medicare patients who saw Dr. Fergus in 2024. The largest group is 75 to 84, with 296 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fergus' median patient age at 69, with 63% women.

In 2024, Dr. Fergus wrote 5,982 Medicare Part D claims for 537 patients. 78% of them were for generic drugs. CMS names the drug for 5,557 of them, across 74 drugs with 11 or more claims each, at $1,656,177 in total drug cost. In 2023, CMS named 5,449 claims across 76 drugs.

Dr. Fergus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fergus as offering telehealth.

Dmand AI links 16 papers to Dr. Fergus, published from 2010 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Coronary Artery Disease, Cardiovascular Agents and Cardiovascular Diseases. Dr. Fergus has published most often in Cardiovasc Drugs Ther. Dr. Fergus' most frequent co-authors are Samin Sharma, MD, Nicholas J. Stamato, MD and Vivian M. Abascal, MD.

CMS Open Payments shows 237 general payments to Dr. Fergus from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Novo Nordisk Inc paid the most, $42,487.

Dr. Fergus graduated from State University of New York Downstate Medical Center in 1992.